Actelion's detailed financials; Comprehensive pipeline breakdown, including molecular targets & partnerships. 17 years of in-depth BioPharma industry [...]

Actelion values partnerships with individual young investigators to advance quality medical care and to enhance patients' lives by supporting clinical [...]

Actelion Pharmaceuticals Announces FDA Approval of Brand Name for Commercially Available VELETRI® (epoprostenol for injection) for Pulmonary Arterial [...]

5 Oct 2010 "Actelion is responsible for ensuring that it has a system in place to keep FDA appropriately apprised of adverse events so that FDA can [...]

Send by www.bloomberg.com

Actelion Ltd. soared the most in more than three years in Swiss trading after the Wall Street Journal reported that the Swiss biotechnology company may sell itself. Actelion has formed a committee of board members to evaluate alternatives, the newspaper said, citing unidentified people familiar with the matter. The committee has hired a financial adviser, it said. [...]

Send by Bloomberg

Actelion Ltd. retreated 1.4 percent after jumping 23 percent last week when the Wall Street Journal reported that Switzerland's largest biotechnology [...]

The US subsidiary of Switzerland-based Actelion, Europe's largest biotechnology firm, says that the US Food and Drug Administration has approved the brand name Veletri for the company's epoprostenol for injection therapy. [...]

Send by Maureen Martino

CONSCIOUS-2 study with clazosentan does not meet primary endpoint ALLSCHWIL/BASEL, SWITZERLAND - 27 September 2010 - Actelion Ltd (SIX: ATLN) announced today the initial results of CONSCIOUS-2 a Read more [...]

Bayer not interested in buying Actelion -sources. Reuters FRANKFURT Oct 8 (Reuters) - German drugmaker Bayer (BAYGn.DE) is not interested in taking over smaller Swiss peer Actelion (ATLN.VX), three sources close to Bayer said, [...]

By Katharina Bart and John Revill, Of DOW JONES NEWSWIRES ZURICH -(Dow Jones)- Shares in Actelion AG (ATLN.VX) surged Friday following a report that Europe's biggest independent biotech is drawing Related Symbols: LSE:GSK. [...]

Homepage - Actelion stellt sich vor. Actelion ist ein biopharmazeutisches Unternehmen mit Hauptsitz in Allschwil/Basel in der Schweiz, das 1997 gegründet wurde und [...]

The FDA has requested a meeting with Actelion Pharmaceuticals' senior management after warning the company for its failure to report postmarket adverse events, including nearly 3500 deaths. [...]

Send by Ed Sliverman

How is this for a difference of opinion? During an inspection of Actelion Pharmaceuticals offices in the summer of 2009, the FDA found the drugmaker was repeatedly failing to follow proper procedures for reporting adverse events and, [...]

Bank Sarasin said Actelion could be of interest to drugmakers looking to sell medicines to treat lung ailments, because the company has built up a sales force to sell Tracleer. "Companies are possibly looking at it because someone could [...]

Send by research

Actelion Pharmaceuticals Ltd-Detailed Product Pipeline report contains detailed information on pipelines by phase and therapeutic indication as well as management information, deals and alliances and recent news on the company including [...]

Send by pregnancy hypertension - Googl

Actelion Pharmaceuticals Ltd: Actelion Pharmaceuticals US, Inc. has received Reuters (press release) Tracleer® is a prescription medication for the treatment of patients with pulmonary arterial hypertension. [...]

This is the limited version of the Actelion company profile: Join LinkedIn or Sign In to see more information. Actelion Pharmaceuticals Ltd is a biopharmaceutical company [...]

Send by Sokolove Law Research & Develo

The Food and Drug Administration (FDA) sent a warning letter last month to Actelion Pharmaceuticals US Inc. for not adhering to post-market drug reporting requirements after it failed to inform the agency of about 3, [...]

Actelion company profile in Cherry Hill, NJ. Our free company profile report for Actelion includes business information such as contact, sales and financial data. [...]

Actelion Pharmaceuticals Us jobs in South San Francisco, Ca from washingtonpost.com. Search all Actelion Pharmaceuticals US jobs to find the best career for you. [...]

In conjunction with the launch of VELETRI, Actelion opened its fourth PAH patient registry in the United States. PROSPECT, the registry to PROSPECTively evaluate use of VELETRI in patients with PAH, is a multicenter, observational, [...]

Send by Senior Editor

FDA Warns Actelion Unit On Post-Marketing Drug Report Failures Wall Street Journal VX) failed to follow the agency's post-marketing drug reporting requirements. In a Sept. 14 warning letter, the FDA said Actelion Pharmaceuticals US Inc. [...]

Send by The Pink Sheet Daily

While still much less frequent than GMP warning letters, PADE letters are on the rise, with FDA focusing on reports for drugs with known serious safety issues. [...]

Send by andri

Actelion is a biopharmaceutical company focused on the discovery, development and commercialization of synthetic, small-molecule drugs to address high unmet medical needs. The company has subsidiaries in more than 25 countries including [...]

Actelion shares jump as M&A talk swirlsReutersZURICH (Reuters) - Shares in Swiss biotech group Actelion (ATLN.VX) surged as much as 12 percent on Friday after a newspaper report fueled talk it could be the next bid target in the [...]